Connected health company Withings is teaming up with digital metabolic health company Calibrate in an effort to integrate the technology from both parties. Specifically, all new Calibrate members will ...

苏格兰爱丁堡和圣地亚哥--(BUSINESS WIRE)--(美国商业资讯)-- (美国商业资讯)--糖尿病患者实时连续血糖监测领域的全球领导者DexCom, Inc.(NASDAQ:DXCM)今天宣布，其Dexcom G7连续血糖监测(CGM)系统已获得CE认证(Conformité Européenne)，适用于欧洲两岁及以上的糖尿病患者，包括孕妇 ...

In 2022, Dexcom began rolling out in Europe the Dexcom One system, a straightforward continuous glucose monitoring setup that stripped away some of the bells and whistles of its flagship G-series CGMs ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase for the first time its new global ...

Dexcom is in seventh heaven: A year after its initial FDA submission, the diabetes tech maker has finally gotten the green light to begin rolling out its latest continuous glucose monitor system in ...

DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter. Patients will be ...

After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...

The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...

Nov 16 (Reuters) - DexCom Inc said it has received approval to calibrate its seven-day continuous glucose monitoring system using any blood glucose meter cleared by the Food and Drug Administration.

The FDA has approved Dexcom's G7 wearable for glucose monitoring for people with all types of diabetes, and the company expects it hit pharmacy shelves in 2023. The wearable is now cleared in the US ...